妖股，“卷土重来”？

Market Overview - The Hong Kong stock market showed mixed performance with the Hang Seng Index slightly down by 0.09% while the Hang Seng China Enterprises Index rose by 0.09% [4] - The overall trading volume in the Hong Kong market was HKD 275.4 billion, with a net inflow of HKD 15.8 billion from southbound funds [4][5] Sector Performance - Dividend sectors such as banking, resources, and public utilities performed well, supporting the rise of the Hang Seng China Enterprises Index [4] - The new energy vehicle sector experienced a decline, with companies like Li Auto, Xpeng Motors, and Leap Motor dropping by 1.51% to 3.92% [7][9] Notable Stock Movements - The stock of药捷安康 (Pharmaron) surged by 46.34%, with an intraday peak increase of 55% [10] - Pharmaron's stock had previously faced a significant drop of over 50% on September 16, but has shown recovery since then [12][17] - Despite the recent surge, Pharmaron's financial performance remains concerning, with losses of CNY 343 million, CNY 275 million, and CNY 123 million reported for 2023, 2024, and the first half of the current year respectively [14] Innovation Drug Sector - The innovation drug sector showed resilience, with companies like 3SBio, Ascletis, and Rongchang Biologics seeing gains of 4.75% to 5.81% [19][22] - The upcoming European Society for Medical Oncology (ESMO) annual meeting is expected to be a focal point for the market, with significant clinical research data anticipated [20] Technology Sector - The technology sector faced challenges, with major companies like Xiaomi and Alibaba experiencing declines of over 3% [23]